CytoSorbents Corp Expands Partnership with Fresenius (NASDAQ: CTSO)

|


(NASDAQ: CTSO) CytoSorbents Corp announced today an expansion in its partnership with Fresenius Medical Care to Mexico and Korea. CytoSorbents is a leader in critical care immunotherapy that can treat potentially lethal inflammation in critically ill patients using its CytoSorb® technology that purifies blood.